Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 2
1951 2
1963 1
1969 1
1972 1
1973 1
1976 1
1979 3
1980 1
1983 4
1984 5
1985 3
1986 2
1987 4
1988 3
1989 6
1990 5
1991 4
1992 3
1993 5
1994 6
1995 12
1996 16
1997 16
1998 10
1999 10
2000 6
2001 6
2002 8
2003 12
2004 16
2005 16
2006 17
2007 30
2008 17
2009 27
2010 41
2011 54
2012 61
2013 52
2014 131
2015 121
2016 107
2017 120
2018 134
2019 136
2020 171
2021 220
2022 259
2023 248
2024 98

Text availability

Article attribute

Article type

Publication date

Search Results

2,037 results

Results by year

Filters applied: . Clear all
Page 1
Dupilumab in Adults and Adolescents with Eosinophilic Esophagitis.
Dellon ES, Rothenberg ME, Collins MH, Hirano I, Chehade M, Bredenoord AJ, Lucendo AJ, Spergel JM, Aceves S, Sun X, Kosloski MP, Kamal MA, Hamilton JD, Beazley B, McCann E, Patel K, Mannent LP, Laws E, Akinlade B, Amin N, Lim WK, Wipperman MF, Ruddy M, Patel N, Weinreich DR, Yancopoulos GD, Shumel B, Maloney J, Giannelou A, Shabbir A. Dellon ES, et al. Among authors: kamal ma. N Engl J Med. 2022 Dec 22;387(25):2317-2330. doi: 10.1056/NEJMoa2205982. N Engl J Med. 2022. PMID: 36546624 Clinical Trial.
Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial.
Paller AS, Simpson EL, Siegfried EC, Cork MJ, Wollenberg A, Arkwright PD, Soong W, Gonzalez ME, Schneider LC, Sidbury R, Lockshin B, Meltzer S, Wang Z, Mannent LP, Amin N, Sun Y, Laws E, Akinlade B, Dillon M, Kosloski MP, Kamal MA, Dubost-Brama A, Patel N, Weinreich DM, Yancopoulos GD, O'Malley JT, Bansal A; participating investigators. Paller AS, et al. Among authors: kamal ma. Lancet. 2022 Sep 17;400(10356):908-919. doi: 10.1016/S0140-6736(22)01539-2. Lancet. 2022. PMID: 36116481 Clinical Trial.
COVID-19 diagnostic methods in developing countries.
Maniruzzaman M, Islam MM, Ali MH, Mukerjee N, Maitra S, Kamal MA, Ghosh A, Castrosanto MA, Alexiou A, Ashraf GM, Tagde P, Rahman MH. Maniruzzaman M, et al. Among authors: kamal ma. Environ Sci Pollut Res Int. 2022 Jul;29(34):51384-51397. doi: 10.1007/s11356-022-21041-z. Epub 2022 May 27. Environ Sci Pollut Res Int. 2022. PMID: 35619009 Free PMC article. Review.
Citrus Essential Oils in Aromatherapy: Therapeutic Effects and Mechanisms.
Agarwal P, Sebghatollahi Z, Kamal M, Dhyani A, Shrivastava A, Singh KK, Sinha M, Mahato N, Mishra AK, Baek KH. Agarwal P, et al. Among authors: kamal m. Antioxidants (Basel). 2022 Nov 30;11(12):2374. doi: 10.3390/antiox11122374. Antioxidants (Basel). 2022. PMID: 36552586 Free PMC article. Review.
Malignant transformation of mature cystic teratoma of the ovary.
Atwi D, Kamal M, Quinton M, Hassell LA. Atwi D, et al. Among authors: kamal m. J Obstet Gynaecol Res. 2022 Dec;48(12):3068-3076. doi: 10.1111/jog.15409. Epub 2022 Sep 2. J Obstet Gynaecol Res. 2022. PMID: 36053141 Review.
CRISPR/Cas9 gene editing: New hope for Alzheimer's disease therapeutics.
Bhardwaj S, Kesari KK, Rachamalla M, Mani S, Ashraf GM, Jha SK, Kumar P, Ambasta RK, Dureja H, Devkota HP, Gupta G, Chellappan DK, Singh SK, Dua K, Ruokolainen J, Kamal MA, Ojha S, Jha NK. Bhardwaj S, et al. Among authors: kamal ma. J Adv Res. 2022 Sep;40:207-221. doi: 10.1016/j.jare.2021.07.001. Epub 2021 Jul 6. J Adv Res. 2022. PMID: 36100328 Free PMC article. Review.
Genomics to select treatment for patients with metastatic breast cancer.
Andre F, Filleron T, Kamal M, Mosele F, Arnedos M, Dalenc F, Sablin MP, Campone M, Bonnefoi H, Lefeuvre-Plesse C, Jacot W, Coussy F, Ferrero JM, Emile G, Mouret-Reynier MA, Thery JC, Isambert N, Mege A, Barthelemy P, You B, Hajjaji N, Lacroix L, Rouleau E, Tran-Dien A, Boyault S, Attignon V, Gestraud P, Servant N, Le Tourneau C, Cherif LL, Soubeyran I, Montemurro F, Morel A, Lusque A, Jimenez M, Jacquet A, Gonçalves A, Bachelot T, Bieche I. Andre F, et al. Among authors: kamal m. Nature. 2022 Oct;610(7931):343-348. doi: 10.1038/s41586-022-05068-3. Epub 2022 Sep 7. Nature. 2022. PMID: 36071165 Clinical Trial.
Nonneoplastic Cervical Cytology.
Kamal M, Topiwala F. Kamal M, et al. Cytojournal. 2022 Mar 29;19:25. doi: 10.25259/CMAS_03_06_2021. eCollection 2022. Cytojournal. 2022. PMID: 35510107 Free PMC article. Review.
Nivolumab plus chemoradiotherapy in locally-advanced cervical cancer: the NICOL phase 1 trial.
Rodrigues M, Vanoni G, Loap P, Dubot C, Timperi E, Minsat M, Bazire L, Durdux C, Fourchotte V, Laas E, Pouget N, Castel-Ajgal Z, Marret G, Lesage L, Meseure D, Vincent-Salomon A, Lecompte L, Servant N, Vacher S, Bieche I, Malhaire C, Huchet V, Champion L, Kamal M, Amigorena S, Lantz O, Chevrier M, Romano E. Rodrigues M, et al. Among authors: kamal m. Nat Commun. 2023 Jun 22;14(1):3698. doi: 10.1038/s41467-023-39383-8. Nat Commun. 2023. PMID: 37349318 Free PMC article. Clinical Trial.
Long-Term Efficacy and Safety of Dupilumab in Adolescents with Moderate-to-Severe Atopic Dermatitis: Results Through Week 52 from a Phase III Open-Label Extension Trial (LIBERTY AD PED-OLE).
Blauvelt A, Guttman-Yassky E, Paller AS, Simpson EL, Cork MJ, Weisman J, Browning J, Soong W, Sun X, Chen Z, Kosloski MP, Kamal MA, Delevry D, Chuang CC, O'Malley JT, Bansal A. Blauvelt A, et al. Among authors: kamal ma. Am J Clin Dermatol. 2022 May;23(3):365-383. doi: 10.1007/s40257-022-00683-2. Epub 2022 May 14. Am J Clin Dermatol. 2022. PMID: 35567671 Free PMC article. Clinical Trial.
2,037 results